Sorrento Therapeutics Inc (SRNE)

[PAUL and Ola]

Why has the approach to this target been stagnant? Why are these Covid portfolios getting nowhere fast? As for the cancer and pain portfolios, my hat is off to Sorrento on this, the clinical trials are progressing in each case ...but, again, slowly. But there is some urgency with regards to Covid because of the elbowing around by competitors, of which there is no lack, and what appears to be favoritism by the FDA to certain chosen ones. It looks corrupt. Oh yeah, and our lobbyists. Duds, or what? Will the second quarter revenue report be out sometime this week? Investors seem to be have no interest in Sorrento. Or is it the shorts? Or both?